JARUL AS AN ANTI DIABETIC DRUG

Pharmacognostic , Phytochemical Studies of Leaf and Fruit of Jarul (lagerstroemia flos reginae)(L.) Pers With Their Comparative Clinical Anti Diabetic Evaluation - D.M

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/09/036516

Enrollment

Registered

2021-09-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E089- Diabetes mellitus due to underlying condition without complications Health Condition 2: E139- Other specified diabetes mellituswithout complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Fasting blood glucose level >1l0& upto 2. Post Prandial blood sugar level >140 & upto 3. Patients between the age group of 20-60 years irrespective of gender. 4. Patients of either sex will be taken.

Exclusion criteria

Exclusion criteria: 1. Patients of Type1 diabetes mellitus. 2. Age below 20 years & above 60 years. 3. Blood sugar-fasting Blood sugar level >200mg/dl 4.Post Prandial blood sugar level >300mg/dl 5.Patient having complication. 6.Other serious medical & surgical ill patient will be excluded 7.Patient cannot follow the dietary regime.

Design outcomes

Primary

Measure	Time frame
Improvement in symptoms of Excessive urination (polyuria) â?¢ Turbidity in urine â?¢Excessive Hunger (Polyphagia) â?¢ Excessive thirst (Polydipsia) â?¢Burning sensation of hands and feet â?¢ Debility â?¢ Weakness â?¢ Weight loss Timepoint: 12 weeks	—

Secondary

Measure	Time frame
Improvement in Blood Sugar Fasting and post-Prandial Bodyweight and B.M.I, Timepoint: 12 weeks	—

Countries

India

Contacts

Public ContactDr Dinesh chandra singh

uttarakhand ayurved university rishikul campus haridwar

dineshcschauhan@gmail.com8954257441

Outcome results